Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06666608 · ClinicalTrials.gov registry record · NA

Bone Stimulator for Spondylolysis

A NA study of Spondylolysis and Symptomatic Spondylolysis, sponsored by The Methodist Hospital Research Institute.

Recruiting
Registry status
NA
Development phase
48
Enrollment target
1
Study location

NCT06666608 is a NA study of Spondylolysis and Symptomatic Spondylolysis that is actively recruiting participants, run by The Methodist Hospital Research Institute. The registered enrollment target is 48 participants, below the 79-participant average among 3 other Spondylolysis trials with a reported enrollment target (39% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06666608, a NA study of Spondylolysis and Symptomatic Spondylolysis, is actively recruiting participants, sponsored by The Methodist Hospital Research Institute.

RECRUITING
Registry status
NA
Development phase
48 participants
Enrollment target
1
Study location

Study Summary

This prospective study aims to investigate the effectiveness of bone stimulator therapy as adjunct treatment of spondylolysis in athletic populations. By evaluating its impact on pain reduction, functional improvement, osseous bony union and return-to-sport time, the investigators seek to provide valuable insights into the role of bone stimulation therapy as a potential treatment modality for this challenging condition.

Interventions

  • DEVICE Bone Stimulator
  • OTHER Standard of Care Spondylolysis Treatment

Study Locations (1)

Texas

  • Houston Methodist Hospital - Houston

Trial Details

FieldValue
Enrollment Target 48 participants
Start Date 2025-09
Est. Completion 2029-12
Phase NA

What the Registry Record Tells You About NCT06666608

The ClinicalTrials.gov registry entry for NCT06666608 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 48 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 79-participant average among 3 other Spondylolysis trials with a reported enrollment target (39% lower). The listed sponsor is The Methodist Hospital Research Institute, which has 126 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Spondylolysis appearing as the primary indexed condition, and to 2 interventions - of which Bone Stimulator is the first listed.

NCT06666608 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.

Frequently Asked Questions

What is clinical trial NCT06666608 about?

NCT06666608 is a clinical study titled "Bone Stimulator for Spondylolysis". This prospective study aims to investigate the effectiveness of bone stimulator therapy as adjunct treatment of spondylolysis in athletic populations. By evaluating its impact on pain reduction, functional improvement, osseous bony union and return-to-sport time, the investigators seek to provide va...

What is the current status of trial NCT06666608?

This trial is currently recruiting. It is a NA study. The enrollment target is 48 participants. The study started on 2025-09. Estimated completion is 2029-12.

What conditions does trial NCT06666608 study?

This clinical trial studies the following conditions: Spondylolysis, Symptomatic Spondylolysis, Athletes.

What interventions are being tested in trial NCT06666608?

The interventions under investigation include: Bone Stimulator (DEVICE), Standard of Care Spondylolysis Treatment (OTHER).

Who is sponsoring clinical trial NCT06666608?

This trial is sponsored by The Methodist Hospital Research Institute, which has 126 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06666608 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Spondylolysis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.